CEACAM5 and cancer: CEA carries α2,6-sialyl residues on its N-glycans whereas a normal counterpart, normal fecal antigen-2 (NFA-2), does not, suggesting that cancer-specific α2,6-sialylation on CEA may play a role in malignant phenotypes such as cell invasion and metastasis.